What is the current respiratory diagnostics market size?

The current respiratory diagnostics market size is approximately USD 8.2 billion as of 2022.

What is the expected growth forecast for the respiratory diagnostics market?

The market is expected to grow at a CAGR of 7.2% from 2023 to 2028.

What are the key drivers of the respiratory diagnostics market?

Increasing prevalence of respiratory diseases and technological advancements are key drivers.

What are the major challenges facing the respiratory diagnostics market?

High costs and limited accessibility in developing regions are major challenges.

Which regions are leading the respiratory diagnostics market?

North America and Europe are leading the market due to high healthcare expenditure.

Who are the top companies in the respiratory diagnostics market?

Top companies include Medtronic, Philips Healthcare, and Siemens Healthineers.

What future opportunities exist in the respiratory diagnostics market?

Emerging markets and point-of-care diagnostics present significant future opportunities.

How is technology impacting the respiratory diagnostics market?

Advances in AI and IoT are improving diagnostic accuracy and patient outcomes.

What is the current regulatory landscape for the respiratory diagnostics market?

Stringent regulations and standards are in place to ensure device safety and efficacy.

What is the future outlook for the respiratory diagnostics market?

The market is expected to experience significant growth due to increasing demand.

respiratory diagnostics Growth Opportunities & Strategic Forecast 2033

respiratory diagnostics by Application (Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users), by Types (Instruments and Devices, Assays and Reagents, Services and Software), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

respiratory diagnostics Market Overview

The respiratory diagnostics market refers to the industry that provides diagnostic tests and devices to detect and monitor respiratory diseases. As the global population ages and the prevalence of respiratory diseases increases, the respiratory diagnostics market size is expected to experience significant growth outlook. The market forecast suggests that the industry will expand rapidly, driven by advances in technology and increasing demand for diagnostic tests. The global respiratory diagnostics market size was approximately $6.8 billion in 2021 and is expected to reach $10.3 billion by 2025, with a compound annual growth rate (CAGR) of 7.3% during the historical range of 2021-2025.

Loading chart…

The respiratory diagnostics market is driven by several key forces, including technology shifts, such as the development of portable and non-invasive diagnostic devices, regulations, such as the increasing demand for diagnostic tests in emerging markets, and consumer behavior, such as the growing awareness of respiratory health. The largest region in the respiratory diagnostics market is North America, while the fastest-growing region is Asia-Pacific. The industry is expected to experience significant industry expansion, driven by the increasing prevalence of respiratory diseases and the growing demand for diagnostic tests.

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	22.98 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Philips Healthcare; Becton, Dickinson; Abbott Laboratories; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The respiratory diagnostics market is poised for significant growth, driven by increasing demand for diagnostic tests and rising prevalence of respiratory diseases. This section provides an overview of the market dynamics, including growth drivers, restraints, opportunities, and challenges, to help stakeholders navigate the landscape and make informed decisions.

Growth Drivers2 items

Advances in technology are driving the development of innovative diagnostic tests, such as molecular diagnostics and point-of-care testing, which are expected to contribute to the growth of the respiratory diagnostics market size.

Increasing awareness about respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, is driving demand for diagnostic tests, further fueling the growth forecast of the market.

Restraints2 items

High costs associated with diagnostic tests and equipment are limiting access to respiratory diagnostics in developing countries, thereby restraining market growth.

Stringent regulation and reimbursement policies are also hindering the adoption of new diagnostic tests and technologies, impacting the overall respiratory diagnostics market.

Opportunities2 items

The growing demand for point-of-care testing and home care diagnostics presents opportunities for manufacturers to develop innovative, user-friendly products that can be used in non-traditional settings.

Partnerships and collaborations between manufacturers, research institutions, and healthcare providers can facilitate the development of new diagnostic tests and technologies, driving growth in the respiratory diagnostics market.

Challenges2 items

The respiratory diagnostics market faces challenges related to the lack of standardization in diagnostic testing, which can lead to variability in test results and interpretation.

Additionally, the market is experiencing intensifying competition among manufacturers, which can lead to pricing pressures and reduced profit margins, making it essential for companies to differentiate their products and services.

Market Segmentation

Loading chart…

The respiratory diagnostics market can be segmented based on application, which includes disease diagnosis, treatment monitoring, and respiratory diagnostics segmentation. This segmentation contributes to the overall market size by providing a clear understanding of the various uses of respiratory diagnostics. For instance, disease diagnosis is a significant application, accounting for a substantial share of the market. This is because respiratory diagnostics play a crucial role in identifying and managing respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia.

Another important segmentation category is types, which includes subtypes such as spirometry, peak flow meters, pulse oximetry, and capnography. These subtypes are essential in understanding the market taxonomy of respiratory diagnostics. Each subtype has its unique characteristics, advantages, and limitations, contributing to the overall market size. For example, spirometry is a widely used diagnostic test for assessing lung function, while peak flow meters are used to monitor asthma and COPD. Understanding these subtypes is essential for analyzing the respiratory diagnostics market.

respiratory diagnostics Segmentation Breakdown9 items

Application

Hospital/Clinical Laboratories

Physician Offices

Reference Laboratories

Other End Users

Types

Instruments and Devices

Assays and Reagents

Services and Software

Regional Insights

Loading chart…

The respiratory diagnostics market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the global market, and also the fastest-growing region, driven by increasing adoption of advanced diagnostic technologies, government policies supporting healthcare infrastructure development, and significant investments in research and development. In contrast, North America, with a share of around 30%, is driven by a mature ecosystem, high infrastructure standards, and a large patient population, while Europe, with a share of around 20%, is driven by a strong regulatory framework, significant demographics with an aging population, and a well-established healthcare system.

In Latin America, with a share of around 10%, regional forecast indicates growth driven by increasing awareness of respiratory diseases, improving healthcare access, and government initiatives to strengthen healthcare infrastructure. The Middle East & Africa region, with a share of around 5%, is expected to grow due to rising demand for diagnostic services, expanding healthcare infrastructure, and increasing foreign investments in the healthcare sector. These factors contribute to the respiratory diagnostics market growth, with each region presenting unique opportunities and challenges.

Competitive Landscape

The respiratory diagnostics market is moderately consolidated, with a mix of global players and local companies competing on various fronts, including pricing, distribution, product innovation, certifications, and regulatory approvals. The respiratory diagnostics competitive landscape is characterized by high competition, with key players employing different strategies to maintain their market position. Global companies tend to dominate the market, but local players are also significant, particularly in emerging economies.

Companies in this market employ various strategies, such as M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves and gain a competitive advantage. However, they face challenges like margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies have adopted distinct strategies:

Philips Healthcare: regional expansion

Becton, Dickinson: vertical integration

Abbott Laboratories: premium pricing

Thermo Fisher Scientific: innovation pipeline

Philips Healthcare: local manufacturing

Becton, Dickinson: OEM tie-ups

Key respiratory diagnostics Companies4 items

Philips Healthcare

Becton, Dickinson

Abbott Laboratories

Thermo Fisher Scientific

Market Ecosystem

The respiratory diagnostics ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three key areas: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers develop diagnostic solutions; and downstream, where channels and end users interact. The value chain analysis of this ecosystem reveals how value is created and captured through the development, distribution, and utilization of respiratory diagnostic products and services.

Raw material/component suppliers — provide critical components

Technology providers — develop diagnostic technologies

OEMs / manufacturers — produce diagnostic equipment

System integrators / EPCs — integrate diagnostic systems

Distributors / channel partners — distribute diagnostic products

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish diagnostic standards

Within the respiratory diagnostics ecosystem, control points are primarily held by regulators and standards bodies, as well as large OEMs and manufacturers, who influence adoption through their products and services. Dependency risks arise from input constraints, such as component shortages, and standards approvals, which can impact the development and distribution of diagnostic solutions. Switching costs and partnerships are also critical, as they can affect the interoperability of diagnostic systems and the ability of end users to transition between different products and services. The respiratory diagnostics ecosystem can differ significantly by region, with varying regulatory requirements, market dynamics, and user needs shaping the development and utilization of diagnostic products and services.

Recent Industry Insights

The respiratory diagnostics industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as collaborations between diagnostic companies and research institutions, have driven innovation in the field. Mergers and acquisitions, like the acquisition of diagnostic firms by larger healthcare companies, have also been prevalent. Furthermore, the launch of new products and technologies, including portable diagnostic devices and artificial intelligence-powered diagnostic platforms, has improved diagnostic accuracy and accessibility.

Regulatory changes, funding rounds, and expansions have also played a crucial role in shaping the respiratory diagnostics market. These developments have contributed to a shift in consumer and enterprise trends, with a growing emphasis on personalized medicine and remote patient monitoring. As the industry continues to evolve, it is likely that we will see even more innovative solutions and strategic collaborations emerge, further transforming the respiratory diagnostics industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the respiratory diagnostics market outlook. The market attractiveness is moderate, driven by an increasing prevalence of respiratory diseases and advancements in diagnostic technologies. Competitive intensity is high, with key players investing heavily in research and development to stay ahead. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with a focus on point-of-care diagnostics and artificial intelligence-powered solutions. Demand-supply balance is expected to be stable, with key risk factors including regulatory changes and intense competition. Overall, the respiratory diagnostics market offers opportunities for growth and innovation, but players must be strategic in their approach to navigate the competitive landscape.

11 items

1. Executive Summary

2. respiratory diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global respiratory diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global respiratory diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital/Clinical Laboratories

6.1.2. Physician Offices

6.1.3. Reference Laboratories

6.1.4. Other End Users

6.2. Global respiratory diagnostics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Instruments and Devices

6.2.2. Assays and Reagents

6.2.3. Services and Software

6.3. Global respiratory diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global respiratory diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global respiratory diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global respiratory diagnostics Market Competition by Key Manufacturers

8.1. Global respiratory diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global respiratory diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Philips Healthcare

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Becton, Dickinson

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Abbott Laboratories

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Thermo Fisher Scientific

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global respiratory diagnostics Market

Figure 4: Global respiratory diagnostics Market: Drivers

Figure 5: Global respiratory diagnostics Market: Challenges

Figure 6: Global respiratory diagnostics Market: Trends

Figure 7: Global respiratory diagnostics Market: Opportunity

Figure 8: Global respiratory diagnostics Market: Restraint

Figure 9: Global respiratory diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global respiratory diagnostics Market Value (USD Million) By Region

Figure 15: Global respiratory diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global respiratory diagnostics Market Value (USD Million) By Region

Figure 23: Global respiratory diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

61 items

Table 1: Market Segmentation Analysis

Table 2: Global respiratory diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global respiratory diagnostics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global respiratory diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global respiratory diagnostics Market Value (USD Million) By Region

Table 10: Global respiratory diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global respiratory diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global respiratory diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global respiratory diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Philips Healthcare Basic Information And Sales Area

Table 31: Philips Healthcare. Products Portfolio

Table 32: Becton, Dickinson Basic Information And Sales Area

Table 33: Becton, Dickinson. Products Portfolio

Table 34: Abbott Laboratories Basic Information And Sales Area

Table 35: Abbott Laboratories. Products Portfolio

Table 36: Thermo Fisher Scientific Basic Information And Sales Area

Table 37: Thermo Fisher Scientific. Products Portfolio

Table 38: Global Market Value (USD Million) (2025-2032) By Application

Table 39: Global Market Share (%) By Application (2032)

Table 40: Global Market Value (USD Million) (2025-2032) By Types

Table 41: Global Market Share (%) By Types (2032)

Table 42: Global respiratory diagnostics Market Value (USD Million) By Region

Table 43: Global respiratory diagnostics Market Share (%) By Region (2025-2032)

Table 44: North America Market Value (USD Million) (2025-2032) By Country

Table 45: North America Market Value (USD Million) (2025-2032) By Application

Table 46: North America Market Value (USD Million) (2025-2032) By Types

Table 47: Europe Market Value (USD Million) (2025-2032) By Country

Table 48: Europe Market Value (USD Million) (2025-2032) By Application

Table 49: Europe Market Value (USD Million) (2025-2032) By Types

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 51: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 53: South America Market Value (USD Million) (2025-2032) By Country

Table 54: South America Market Value (USD Million) (2025-2032) By Application

Table 55: South America Market Value (USD Million) (2025-2032) By Types

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 57: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 59: Research Programs/Design For This Report

Table 60: Key Data Information From Secondary Sources

Table 61: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

respiratory diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	22.98 million
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Philips Healthcare; Becton, Dickinson; Abbott Laboratories; Thermo Fisher Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High costs associated with diagnostic tests and equipment are limiting access to respiratory diagnostics in developing countries, thereby restraining market growth.

Stringent regulation and reimbursement policies are also hindering the adoption of new diagnostic tests and technologies, impacting the overall respiratory diagnostics market.

Opportunities2 items

Challenges2 items

The respiratory diagnostics market faces challenges related to the lack of standardization in diagnostic testing, which can lead to variability in test results and interpretation.

Market Segmentation

Loading chart…

respiratory diagnostics Segmentation Breakdown9 items

Application

Hospital/Clinical Laboratories

Physician Offices

Reference Laboratories

Other End Users

Types

Instruments and Devices

Assays and Reagents

Services and Software

Regional Insights

Loading chart…

Competitive Landscape

Philips Healthcare: regional expansion

Becton, Dickinson: vertical integration

Abbott Laboratories: premium pricing

Thermo Fisher Scientific: innovation pipeline

Philips Healthcare: local manufacturing

Becton, Dickinson: OEM tie-ups

Key respiratory diagnostics Companies4 items

Philips Healthcare

Becton, Dickinson

Abbott Laboratories

Thermo Fisher Scientific

Market Ecosystem

Raw material/component suppliers — provide critical components

Technology providers — develop diagnostic technologies

OEMs / manufacturers — produce diagnostic equipment

System integrators / EPCs — integrate diagnostic systems

Distributors / channel partners — distribute diagnostic products

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish diagnostic standards

Recent Industry Insights

Analyst Overview

Table of Contents